Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIGB-300 in Genital Condyloma
NCT01639638Phase 3Terminated
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of cigb-300 in condylomata acuminata, sponsored by Laboratorio Elea Phoenix S.A.. Started Jun 2010; status: terminated.
02
Drugs
cigb-300
03
Conditions
condylomata acuminata
Beyond the preview
Go deeper on NCT01639638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639638.